Singapore markets close in 4 hours 58 minutes

Cardiol Therapeutics Inc. (CT9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.6040+0.0140 (+0.88%)
At close: 08:13AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 113.75M
Enterprise value 90.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.63
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.05

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3183.93%
S&P500 52-week change 325.01%
52-week high 31.9100
52-week low 30.4920
50-day moving average 31.4980
200-day moving average 31.0179

Share statistics

Avg vol (3-month) 31.43k
Avg vol (10-day) 3700
Shares outstanding 568.27M
Implied shares outstanding 671.54M
Float 865.18M
% held by insiders 14.42%
% held by institutions 113.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.71%
Return on equity (ttm)-69.93%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -29.59M
Net income avi to common (ttm)-28.13M
Diluted EPS (ttm)-0.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.93M
Total cash per share (mrq)0.51
Total debt (mrq)174.34k
Total debt/equity (mrq)0.62%
Current ratio (mrq)4.36
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-25.18M
Levered free cash flow (ttm)-14.99M